• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday

    9/7/22 5:16:07 AM ET
    $ADT
    $ADTN
    $AIMD
    $AKA
    Diversified Commercial Services
    Consumer Discretionary
    Telecommunications Equipment
    Utilities
    Get the next $ADT alert in real time by email

    Gainers

    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
    • IVERIC bio, Inc. (NASDAQ:ISEE) rose 66.3% to close at $15.70 on Tuesday after the company announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA).
    • HyreCar Inc. (NASDAQ:HYRE) climbed 58.1% to close at $1.27 on Tuesday after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
    • Spero Therapeutics, Inc. (NASDAQ:SPRO) gained 55.5% to close at $1.13. Spero Therapeutics received minutes from a recent Type A meeting with the FDA, discussing steps required to resubmit the marketing application for tebipenem HBr for complicated urinary tract infection (cUTI).
    • ChannelAdvisor Corporation (NYSE:ECOM) shares jumped 55% to settle at $22.79 after the company announced it will be acquired by CommerceHub for $23.10 per share.
    • Akumin Inc. (NASDAQ:AKU) climbed 37% to close at $1.63. Akumin recently received notification letter from the Nasdaq confirming that company had regained compliance with minimum bid price requirement.
    • Apexigen, Inc. (NASDAQ:APGN) rose 34.4% to close at $7.03.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares gained 32.7% to close at $4.22 after gaining 7% on Friday.
    • Galera Therapeutics, Inc. (NASDAQ:GRTX) jumped 29.5% to settle at $1.67. Galera Therapeutics, last month, posted a Q2 loss of $0.54 per share.
    • HilleVax, Inc. (NASDAQ:HLVX) rose 24.8% to close at $17.05. HilleVax recently said Safety Data Monitoring Committee has recommended continuation of NEST-IN1 Phase 2b clinical trial.
    • T Stamp Inc. (NASDAQ:IDAI) gained 24.6% to close at $1.72.
    • Sunrise New Energy Co., Ltd. (NASDAQ:EPOW) jumped 24.6% to close at $3.49.
    • Avaya Holdings Corp. (NASDAQ:AVYA) gained 24% to close at $2.12.
    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) rose 22.3% to settle at $5.87.
    • Avalo advanced BTLA agonist fusion protein (AVTX-008) to IND-enabling stage.
    • BioVie Inc. (NASDAQ:BIVI) rose 21.6% to close at $3.44.
    • Ainos, Inc. (NASDAQ:AIMD) gained 21.1% to close at $2.24. Ainos recently submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for conducting a Phase 2 trial of its drug candidate VELDONA, for treatment of mild symptoms related to COVID-19.
    • Neonode Inc. (NASDAQ:NEON) jumped 18.7% to settle at $4.26. Neonode, last month, posted a Q2 loss of $0.11 per share.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) gained 18.4% to close at $5.80.
    • a.k.a. Brands Holding Corp. (NYSE:AKA) surged 17.4% to settle at $2.36.
    • SelectQuote, Inc. (NYSE:SLQT) climbed 16.8% to settle at $1.11. SelectQuote recently said Q4 sales results were lower year-over-year and issued FY23 sales guidance below analyst estimates.
    • ADT Inc. (NYSE:ADT) rose 16.4% to close at $8.39 after the company announced it has secured investments totaling $1.5 billion from State Farm and Google.
    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) gained 15.3% to close at $0.70. Dermata Therapeutics recently posted a Q2 loss of $0.24 per share
    • Regulus Therapeutics Inc. (NASDAQ:RGLS) gained 14.1% to close at $1.62. Regulus Therapeutics, last month, posted a Q2 loss of $0.50 per share.
    • Organovo Holdings, Inc. (NASDAQ:ONVO) rose 13.4% to close at $2.62.
    • Dakota Gold Corp. (NYSE:DC) gained 12.6% to close at $3.48.
    • SES AI Corporation (NYSE:SES) gained 10.5% to close at $5.17.
    • CytomX Therapeutics, Inc. (NASDAQ:CTMX) rose 10.3% to close at $1.61. CytomX Therapeutics, last month, posted a Q2 loss of $0.37 per share.
    • Nordic American Tankers Limited (NYSE:NAT) climbed 10% to settle at $2.86. Jefferies upgraded Nordic American Tankers from Hold to Buy and raised the price target from $3 to $4.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) climbed 9.9% to close at $0.3520 after gaining around 5% on Friday.
    • Zeta Global Holdings Corp. (NYSE:ZETA) gained 9.6% to close at $7.00.
    • Belite Bio, Inc (NASDAQ:BLTE) gained 9.2% to close at $38.11.
    • Wingstop Inc. (NASDAQ:WING) jumped 9.1% to close at $132.04.
    • Frontline Ltd. (NYSE:FRO) rose 9% to settle at $12.99 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $11 to $16.
    • Tellurian Inc. (NASDAQ:TELL) gained 9.1% to close at $4.45.
    • Nutex Health, Inc. (NASDAQ:NUTX) gained 8.8% to close at $2.60. Nutex Health recently reported Q2 earnings results.
    • Euronav NV (NYSE:EURN) jumped 8.8% to settle at $17.65 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $14 to $20.
    • Outfront Media Inc. (NYSE:OUT) rose 6.8% to settle at $18.46 after it was announced the company is set to join the S&P SmallCap 600.

     


    Don’t forget to check out our premarket coverage here .

    Losers

    • Creatd, Inc. (NASDAQ:CRTD) shares declined 48.1% to close at $0.1950 after dipping 31% on Friday. Creatd received delist decision and received 15 days to file appeal.
    • Addentax Group Corp. (NASDAQ:ATXG) shares fell 39.5% to close at $5.80 following the company's uplisting and IPO.
    • Rigetti Computing, Inc. (NASDAQ:RGTI) dropped 37.1% to close at $2.29.
    • Presidio Property Trust, Inc. (NASDAQ:SQFT) fell 33.9% to close at $2.08. Presidio Property Trust declared Q3 dividend and adopted variable dividend policy.
    • Tupperware Brands Corporation (NYSE:TUP) fell 33.2% to close at $7.36.
    • AN2 Therapeutics, Inc. (NASDAQ:ANTX) dropped 32.9% to settle at $8.57.
    • ProKidney Corp. (NASDAQ:PROK) shares dipped 31.4% to close at $7.00 on Tuesday. ProKidney recently named Glenn Schulman, PharmD, MPH, as Senior Vice President of Investor Relations.
    • AMTD Digital Inc. (NYSE:HKD) fell 31.1% to close at $68.95 amid a rise in treasury yields, which has caused a selloff in growth stocks.
    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) fell 30.6% to close at $0.0727 after the company announced it has filed for bankruptcy.
    • Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) shares fell 29.4% to close at $6.04 after the company provided an update on the status of its planned request for EUA of peginterferon lambda, saying "the agency has indicated that it is not yet able to determine whether the criteria for the submission of an application and issuance of an EUA are likely to be met."
    • Zymeworks Inc. (NASDAQ:ZYME) declined 28.9% to close at $4.76.
    • POINT Biopharma Global Inc. (NASDAQ:PNT) fell 28.6% to close at $7.31.
    • PaxMedica, Inc. (NASDAQ:PXMD) declined 28.6% to close at $3.69 following the company's recent IPO.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) fell 27.8% to close at $3.76.
    • bioAffinity Technologies, Inc. (NASDAQ:BIAF) fell 23.6% to close at $5.39 after dropping 15% on Friday. The company, last week, priced its IPO at $6.125 per unit.
    • Cheetah Mobile Inc. (NYSE:CMCM) fell 23.5% to close at $2.83.
    • Forza X1, Inc. (NASDAQ:FRZA) dropped 22.6% to close at $3.40. Forza X1, last month, entered into a strategic partnership with premium marine retailer OneWater to create a distribution channel for its integrated electric sports boats.
    • Jianzhi Education Technology Group Company Limited (NASDAQ:JZ) fell 21.6% to close at $4.17.
    • Nuwellis, Inc. (NASDAQ:NUWE) dipped 21.6% to close at $0.9641.
    • FaZe Holdings Inc. (NASDAQ:FAZE) fell 21.2% to settle at $13.73.
    • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) fell 21% to close at $9.07.
    • TherapeuticsMD, Inc. (NASDAQ:TXMD) dropped 20.4% to settle at $8.10.
    • TherapeuticsMD, last month, said Q2 EPS results were higher year over year.
    • Avalon GloboCare Corp. (NASDAQ:AVCO) declined 19.6% to close at $0.4950.
    • Hempacco Co., Inc. (NASDAQ:HPCO) fell 19.3% to close at $4.55.
    • Gravitas Education Holdings, Inc. (NYSE:GEHI) dipped 18.7% to close at $0.61.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) dipped 18.6% to close at $2.7426.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) fell 18.4% to close at $7.04 following the passing of CFO Gustavo Arnal. Raymond James recently downgraded the stock form Market Perform to Underperform.
    • Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) fell 16.6% to close at $2.21 after climbing around 27% on Friday.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) declined 16.2% to close at $2.53 following downbeat quarterly sales.
    • MoonLake Immunotherapeutics (NASDAQ:MLTX) dipped 16.1% to close at $7.22.
    • Sera Prognostics, Inc. (NASDAQ:SERA) fell 15.5% to close at $1.69. Sera Prognostics, last month, posted a Q2 loss of $0.37 per share.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) declined 14.2% to settle at $9.59 amid a rise in treasury yields, which has caused a selloff in growth stocks.
    • ShiftPixy, Inc. (NASDAQ:PIXY) fell 14% to close at $11.70.
    • eHealth, Inc. (NASDAQ:EHTH) fell 14% to close at $4.86.
    • iQIYI, Inc. (NASDAQ:IQ) fell 13.9% to close at $3.04 amid continued COVID-19 lockdowns in China.
    • CalAmp Corp. (NASDAQ:CAMP) fell 13.6% to close at $4.71.
    • Tango Therapeutics, Inc. (NASDAQ:TNGX) fell 12.6% to close at $3.74.
    • Burcon NutraScience Corporation (NASDAQ:BRCN) fell 12.2% to close at $0.4564 as the company reported delisting from Nasdaq Capital Market on or about September 12. The company also announced auditor resignation and postponement of annual meeting of shareholders.
    • Glatfelter Corporation (NYSE:GLT) fell 11.7% to close at $4.36. Glatfelter recently named Mr. Thomas Fahnemann as President and Chief Executive Officer.
    • Digital World Acquisition Corp (NASDAQ:DWAC) shares fell 11.4% to close at $22.13. Shareholders have rejected the special purpose acquisition company’s proposal to extend by a year the deadline for its merger with former President Donald Trump’s Trump Media & Technology, which operates the Truth Social platform, Reuters reported.
    • HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE) fell 11.1% to settle at $4.26. HIVE reported its August 2022 production figures and mining capacity.
    • Futu Holdings Limited (NASDAQ:FUTU) fell 10.6% to close at $43.72 amid continued COVID-19 lockdowns in China.
    • ADTRAN Holdings, Inc. (NASDAQ:ADTN) fell 10.5% to close at $20.31.
    • ASAP, Inc. (NASDAQ:WTRH) fell 10.3% to close at $0.2070.
    • Cytokinetics, Incorporated (NASDAQ:CYTK) dropped 9.1% to close at $49.17. Cytokinetics, last month, reported better-than-expected Q2 EPS and sales results.
    • Getty Images Holdings, Inc. (NYSE:GETY) fell 8.5% to close at $13.61.
    • GameStop Corp. (NYSE:GME) fell 8.1% to close at $25.14.
    • Hillenbrand, Inc. (NYSE:HI) dropped 7% to close at $37.74. The company, last month, posted upbeat quarterly results.
    Get the next $ADT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADT
    $ADTN
    $AIMD
    $AKA

    CompanyDatePrice TargetRatingAnalyst
    Rigetti Computing Inc.
    $RGTI
    2/12/2026Buy → Hold
    TD Cowen
    Kingsoft Cloud Holdings Limited
    $KC
    2/11/2026$15.60Neutral → Buy
    Goldman
    Wingstop Inc.
    $WING
    2/10/2026$285.00Buy → Hold
    TD Cowen
    Wingstop Inc.
    $WING
    2/10/2026$325.00Strong Buy → Outperform
    Raymond James
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    Futu Holdings Limited
    $FUTU
    2/2/2026$213.39Neutral → Buy
    Goldman
    Cytokinetics Incorporated
    $CYTK
    1/28/2026$87.00Overweight
    Barclays
    HIVE Digital Technologies Ltd.
    $HIVE
    1/27/2026$3.50Outperform → Mkt Perform
    Keefe Bruyette
    More analyst ratings

    $ADT
    $ADTN
    $AIMD
    $AKA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Director Attal Alain bought $259,577 worth of shares (12,000 units at $21.63), increasing direct ownership by 2% to 596,464 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/21/26 6:32:09 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ADT
    $ADTN
    $AIMD
    $AKA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Sawhney Inderpreet returned 587 shares to the company (SEC Form 4)

    4/A - Hillenbrand, Inc. (0001417398) (Issuer)

    2/12/26 7:46:58 PM ET
    $HI
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Chief Financial Officer Dolan John Joseph covered exercise/tax liability with 1,738 shares, decreasing direct ownership by 0.94% to 183,755 units (SEC Form 4)

    4 - eHealth, Inc. (0001333493) (Issuer)

    2/12/26 4:25:30 PM ET
    $EHTH
    Specialty Insurers
    Finance

    SEC Form 3 filed by new insider Schultz Carisa

    3 - Nuwellis, Inc. (0001506492) (Issuer)

    2/12/26 4:15:30 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ADT
    $ADTN
    $AIMD
    $AKA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rigetti Computing downgraded by TD Cowen

    TD Cowen downgraded Rigetti Computing from Buy to Hold

    2/12/26 7:23:36 AM ET
    $RGTI
    EDP Services
    Technology

    Kingsoft Cloud upgraded by Goldman with a new price target

    Goldman upgraded Kingsoft Cloud from Neutral to Buy and set a new price target of $15.60

    2/11/26 7:42:03 AM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    Wingstop downgraded by TD Cowen with a new price target

    TD Cowen downgraded Wingstop from Buy to Hold and set a new price target of $285.00

    2/10/26 8:00:55 AM ET
    $WING
    Restaurants
    Consumer Discretionary

    $ADT
    $ADTN
    $AIMD
    $AKA
    SEC Filings

    View All

    SEC Form 144 filed by Zymeworks Inc.

    144 - Zymeworks Inc. (0001937653) (Subject)

    2/13/26 9:00:01 PM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by ADT Inc.

    SCHEDULE 13G/A - ADT Inc. (0001703056) (Subject)

    2/13/26 5:37:51 PM ET
    $ADT
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form S-8 filed by Ainos Inc.

    S-8 - Ainos, Inc. (0001014763) (Filer)

    2/13/26 4:28:39 PM ET
    $AIMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADT
    $ADTN
    $AIMD
    $AKA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for IZERVAY issued to IVERIC BIO, INC.

    Submission status for IVERIC BIO, INC.'s drug IZERVAY (ORIG-1) with active ingredient AVACINCAPTAD PEGOL has changed to 'Approval' on 08/04/2023. Application Category: NDA, Application Number: 217225, Application Classification: Type 1 - New Molecular Entity

    8/9/23 8:37:19 AM ET
    $ISEE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug IMVEXXY (SUPPL-2) with active ingredient ESTRADIOL has changed to 'Approval' on 11/16/2021. Application Category: NDA, Application Number: 208564, Application Classification: Labeling

    11/17/21 4:38:32 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADT
    $ADTN
    $AIMD
    $AKA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RETRANSMISSION: HIVE's BUZZ Signs $30 Million in AI Cloud Contracts, Accelerating Global HPC Tier-III Data Center Expansion

    This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated November 25, 2025 to its short form base shelf prospectus dated October 31, 2025.San Antonio, Texas--(Newsfile Corp. - February 13, 2026) - BUZZ High Performance Computing ("BUZZ"), the Canadian Tier-III high-performance computing ("HPC") data center platform of HIVE Digital Technologies Ltd. (TSXV:HIVE) (NASDAQ:HIVE) (FSE: YO0) (BVC: HIVECO) ("HIVE" or the "Company"), today announced a major step forward in its AI cloud strategy, signing customer agreements representing approximately $30 million in total contract value over two-year fixed terms, subject to performance obli

    2/13/26 6:00:00 AM ET
    $HIVE
    Finance: Consumer Services
    Finance

    HIVE's BUZZ Signs $30 Million in AI Cloud Contracts, Accelerating Global HPC Tier-III Data Center Expansion

    This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated November 25, 2025 to its short form base shelf prospectus dated October 31, 2025.San Antonio, Texas--(Newsfile Corp. - February 13, 2026) - BUZZ High Performance Computing ("BUZZ"), the Canadian Tier-III high-performance computing ("HPC") data center platform of HIVE Digital Technologies Ltd. (TSXV:HIVE) (NASDAQ:HIVE) (FSE: YO0) (BVC: HIVECO) ("HIVE" or the "Company"), today announced a major step forward in its AI cloud strategy, signing customer agreements representing approximately $30 million in total contract value over two-year fixed terms, subject to performance obli

    2/13/26 1:00:00 AM ET
    $HIVE
    Finance: Consumer Services
    Finance

    Cytokinetics to Announce Fourth Quarter Results on February 24, 2026

    SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that it is scheduled to report fourth quarter results on February 24, 2026 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 PM Eastern Time to discuss financial results and provide business updates. The conference call will be simultaneously webcast and can be accessed from the Investors & Media section of Cytokinetics' website at www.cytokinetics.com or directly at the following link: Cytokinetics Q4 2025 Earnings Conference Call. An archived replay of the webcast will be available via Cytokinetics'

    2/12/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADT
    $ADTN
    $AIMD
    $AKA
    Leadership Updates

    Live Leadership Updates

    View All

    ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

    Brings 20+ years of clinical development experience in autoimmune and inflammatory diseases, including OX40/OX40L program leadership Will build and lead Imagene's clinical organization and drive completion of the Phase 2b ADAPTIVE trial in atopic dermatitis Will expand Phase 2b trial footprint with planned international sites including in the UK and Europe SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (NASDAQ:IMA, "Imagene, " or the "Company")), today announced the appointment of Dr. Ben Porter-Brown, a seasoned autoimmune and inflammatory drug developer with experience in the OX40 receptor-ligand (OX40-OX40L) inhibition field, as its Chief Medical Officer. He will be fo

    2/10/26 7:00:00 AM ET
    $IMA
    $MLTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    RingCentral Set to Join S&P SmallCap 600

    NEW YORK, Feb. 9, 2026 /PRNewswire/ -- RingCentral Inc. (NYSE:RNG) will replace Hillenbrand Inc. (NYSE:HI) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 12. Lone Star Funds is acquiring Hillenbrand in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Feb 12, 2026 S&P SmallCap 600 Addition RingCentral RNG Information Technology Feb 12, 2026 S&P SmallCap 600 Deletion Hillenbrand HI Industrials ABOUT S&P DOW JONES INDICES S&P Dow Jones Indices is the large

    2/9/26 6:08:00 PM ET
    $HI
    $RNG
    $SPGI
    Miscellaneous manufacturing industries
    Consumer Discretionary
    EDP Services
    Technology

    Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

    NEW YORK, Feb. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600:  S&P MidCap 400 constituent Ciena Corp. (NYSE:CIEN) will replace Dayforce Inc. (NYSE:DAY) in the S&P 500, S&P SmallCap 600 constituent Arrowhead Pharmaceuticals Inc. (NASD: ARWR) will replace Ciena in the S&P MidCap 400, and ADT Inc. (NYSE:ADT) will replace Arrowhead Pharmaceuticals in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 9. Thoma Bravo L.P. acquired Dayforce in a deal that closed today.OneSpaWorld Holdings Ltd. (NASD: OSW) will replace Dynavax Technologies Corp. (NASD: DVAX) in the S&P SmallCap 600 effec

    2/4/26 6:15:00 PM ET
    $ADT
    $ARWR
    $CIEN
    Diversified Commercial Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADT
    $ADTN
    $AIMD
    $AKA
    Financials

    Live finance-specific insights

    View All

    Cytokinetics to Announce Fourth Quarter Results on February 24, 2026

    SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that it is scheduled to report fourth quarter results on February 24, 2026 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 PM Eastern Time to discuss financial results and provide business updates. The conference call will be simultaneously webcast and can be accessed from the Investors & Media section of Cytokinetics' website at www.cytokinetics.com or directly at the following link: Cytokinetics Q4 2025 Earnings Conference Call. An archived replay of the webcast will be available via Cytokinetics'

    2/12/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RETRANSMISSION: HIVE Digital Technologies to Release Fiscal Q3 2026 Financial Results and Hold Earnings Call on February 17

    San Antonio, Texas--(Newsfile Corp. - February 12, 2026) - HIVE Digital Technologies Ltd. (TSXV:HIVE) (NASDAQ:HIVE) (FSE: YO0) (BVC: HIVECO) (the "Company" or "HIVE"), a diversified global leader in renewable-powered blockchain and AI infrastructure, today announced it will release its financial results for the nine months ended December 31, 2025 on Tuesday, February 17, 2026, followed by an earnings conference call and webcast on Tuesday, February 17, 2026, at 8:00 AM EST.Conference Call InformationTo participate in this event, please log on or dial in approximately 5 minutes before the call.Date: February 17, 2026Time: 8:00 AM EST Webcast: Registration link here. Dial-in: Provided after re

    2/12/26 6:00:00 AM ET
    $HIVE
    Finance: Consumer Services
    Finance

    Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026

    VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will report its fourth quarter and full year 2025 financial results pre-market on March 2, 2026. Following the announcement, management will host a conference call and webcast to discuss financial results and provide a corporate update on March 2, 2026 at 8:30 am Eastern Time (ET). About Zymeworks Inc. Zymeworks is a global biotechnology company managing a portfolio of licensed healthcare assets and developing a

    2/12/26 6:00:00 AM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADT
    $ADTN
    $AIMD
    $AKA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13D/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/9/24 5:54:19 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13G/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/5/24 5:28:41 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G filed by Rigetti Computing Inc.

    SC 13G - Rigetti Computing, Inc. (0001838359) (Subject)

    12/5/24 10:15:39 AM ET
    $RGTI
    EDP Services
    Technology